Tvardi Therapeutics (TVRD) Stock Price Target 2026

The average analyst price target for Tvardi Therapeutics is $11.38, 1212.4% above the current price. Of 10 analysts, 8 rate it Buy, 1 Hold and 1 Sell. Targets range from $3 to $39. The latest change came on Oct 20, 2026, when Chardan Capital initiated coverage of Tvardi Therapeutics with a Buy rating and a $8 price target.